Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1282
| Despition | Siah E3 Ubiquitin Protein Ligase 1 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 95% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1348 | Presenilin 1 Blocking Peptide (AC1348) | 250 µg | inquiry |
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1081 | Human NRN1 Protein (AC1081) | 5 µg | inquiry |
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
| ACPP-1388 | Human FDX1 Protein (AC1388) | 5 µg | inquiry |
| ACPP-1746 | Human Acrp30 Protein (AC1746) | 10 µg | inquiry |
| ACPP-1843 | Human PON1 Protein (AC1843) | 2 µg | inquiry |
| ACPP-1342 | ORP150 Blocking Peptide (AC1342) | 250 µg | inquiry |
| ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
| ACPP-1828 | Human EPHA2 Protein (AC1828) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.